Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America

Hicham Skali; Venkatesh L. Murthy; Diana Paez; Elisa M. Choi; Felix Y.J. Keng; McGhie G.A. Iain; Mouaz Al-Mallah; Roxana Campisi; Timothy M. Bateman; Ignasi Carrio; Rob Beanlands; Dennis A. Calnon; Vasken Dilsizian; Maurizio Dondi; Alessia Gimelli; Robert Pagnanelli; Donna M. Polk; Prem Soman; Andrew J. Einstein; Sharmila Dorbala; Randall C. Thompson

doi:10.1007/s12350-020-02203-3

Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America

Hicham Skali, Venkatesh L. Murthy, Diana Paez, Elisa M. Choi, Felix Y.J. Keng, McGhie G.A. Iain, Mouaz Al-Mallah, Roxana Campisi, Timothy M. Bateman, Ignasi Carrio, Rob Beanlands, Dennis A. Calnon, Vasken Dilsizian, Maurizio Dondi, Alessia Gimelli, Robert Pagnanelli, Donna M. Polk, Prem Soman, Andrew J. Einstein, Sharmila DorbalaRandall C. Thompson

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Original language	English (US)
Pages (from-to)	1855-1862
Number of pages	8
Journal	Journal of Nuclear Cardiology
Volume	27
Issue number	5
DOIs	https://doi.org/10.1007/s12350-020-02203-3
State	Published - Oct 1 2020

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s12350-020-02203-3

Cite this

Skali, H., Murthy, V. L., Paez, D., Choi, E. M., Keng, F. Y. J., Iain, M. G. A., Al-Mallah, M., Campisi, R., Bateman, T. M., Carrio, I., Beanlands, R., Calnon, D. A., Dilsizian, V., Dondi, M., Gimelli, A., Pagnanelli, R., Polk, D. M., Soman, P., Einstein, A. J., ... Thompson, R. C. (2020). Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America. Journal of Nuclear Cardiology, 27(5), 1855-1862. https://doi.org/10.1007/s12350-020-02203-3

Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America. / Skali, Hicham; Murthy, Venkatesh L.; Paez, Diana et al.
In: Journal of Nuclear Cardiology, Vol. 27, No. 5, 01.10.2020, p. 1855-1862.

Research output: Contribution to journal › Article › peer-review

Skali, H, Murthy, VL, Paez, D, Choi, EM, Keng, FYJ, Iain, MGA, Al-Mallah, M, Campisi, R, Bateman, TM, Carrio, I, Beanlands, R, Calnon, DA, Dilsizian, V, Dondi, M, Gimelli, A, Pagnanelli, R, Polk, DM, Soman, P, Einstein, AJ, Dorbala, S & Thompson, RC 2020, 'Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America', Journal of Nuclear Cardiology, vol. 27, no. 5, pp. 1855-1862. https://doi.org/10.1007/s12350-020-02203-3

Skali H, Murthy VL, Paez D, Choi EM, Keng FYJ, Iain MGA et al. Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America. Journal of Nuclear Cardiology. 2020 Oct 1;27(5):1855-1862. doi: 10.1007/s12350-020-02203-3

Skali, Hicham ; Murthy, Venkatesh L. ; Paez, Diana et al. / Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic : An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America. In: Journal of Nuclear Cardiology. 2020 ; Vol. 27, No. 5. pp. 1855-1862.

@article{e8f4eca460304508b430010e954b742a,

title = "Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America",

author = "Hicham Skali and Murthy, {Venkatesh L.} and Diana Paez and Choi, {Elisa M.} and Keng, {Felix Y.J.} and Iain, {McGhie G.A.} and Mouaz Al-Mallah and Roxana Campisi and Bateman, {Timothy M.} and Ignasi Carrio and Rob Beanlands and Calnon, {Dennis A.} and Vasken Dilsizian and Maurizio Dondi and Alessia Gimelli and Robert Pagnanelli and Polk, {Donna M.} and Prem Soman and Einstein, {Andrew J.} and Sharmila Dorbala and Thompson, {Randall C.}",

note = "Funding Information: Dr. Bateman: Activities related to the present article: No relevant relationships. Activities not related to the present article: Research Grants: Bracco, GE Healthcare, Jubilant DraxImage. Consultant: AIM, AstraZeneca, Curium, GEHC. Royalties: SPECT and PET software products. Ownership interest: CVIT. Dr. Beanlands: Activities related to the present article: No relevant relationships. Activities not related to the present article: Grants/Honoraria from Jubilant DraxImage, LMI, GE Healthcare. Dr. Dorbala: Activities related to the present article: No relevant relationships. Activities not related to the present article: Grants and Honoraria from Pfizer and GE Healthcare. Institution has grants/grants pending from National Institutes of Health and International Atomic Energy Agency. Dr. Einstein: Activities related to the present article: No relevant relationships. Activities not related to the present article: Consultant for GE Healthcare and W. L. Gore and Associates; institution has grants/grants pending from National Institutes of Health, International Atomic Energy Agency, Canon Medical Systems, Roche Medical Systems, and W. L. Gore and Associates; received travel/accommodations/meeting expenses unrelated to activities listed from HeartFlow. Dr. Murthy: Activities related to the present article: No relevant relationships. Activities not related to the present article: Owns stock in General Electric and Cardinal Health and stock options in Ionetix. He has served as a paid advisor to Ionetix and Covidien. He has received research grants from Siemens and non-financial research support from INVIA Medical Imaging Solutions. He has received payment on behalf of Jubilant Draximage for expert witness testimony. Dr. Soman: Activities related to the present article: No relevant relationships. Activities not related to the present article: Serves on the advisory board of Alnylam Pharmaceuticals and is the principal investigator of a grant from Astellas Pharmaceuticals to the University of Pittsburgh. The remaining authors have no relevant relationships. Funding Information: Dr. Bateman: Activities related to the present article: No relevant relationships. Activities not related to the present article: Research Grants: Bracco, GE Healthcare, Jubilant DraxImage. Consultant: AIM, AstraZeneca, Curium, GEHC. Royalties: SPECT and PET software products. Ownership interest: CVIT. Dr. Beanlands: Activities related to the present article: No relevant relationships. Activities not related to the present article: Grants/Honoraria from Jubilant DraxImage, LMI, GE Healthcare. Dr. Dorbala: Activities related to the present article: No relevant relationships. Activities not related to the present article: Grants and Honoraria from Pfizer and GE Healthcare. Institution has grants/grants pending from National Institutes of Health and International Atomic Energy Agency. Dr. Einstein: Activities related to the present article: No relevant relationships. Activities not related to the present article: Consultant for GE Healthcare and W. L. Gore and Associates; institution has grants/grants pending from National Institutes of Health, International Atomic Energy Agency, Canon Medical Systems, Roche Medical Systems, and W. L. Gore and Associates; received travel/accommodations/meeting expenses unrelated to activities listed from HeartFlow. Dr. Murthy: Activities related to the present article: No relevant relationships. Activities not related to the present article: Owns stock in General Electric and Cardinal Health and stock options in Ionetix. He has served as a paid advisor to Ionetix and Covidien. He has received research grants from Siemens and non-financial research support from INVIA Medical Imaging Solutions. He has received payment on behalf of Jubilant Draximage for expert witness testimony. Dr. Soman: Activities related to the present article: No relevant relationships. Activities not related to the present article: Serves on the advisory board of Alnylam Pharmaceuticals and is the principal investigator of a grant from Astellas Pharmaceuticals to the University of Pittsburgh. The remaining authors have no relevant relationships. ",

year = "2020",

month = oct,

day = "1",

doi = "10.1007/s12350-020-02203-3",

language = "English (US)",

volume = "27",

pages = "1855--1862",

journal = "Journal of Nuclear Cardiology",

issn = "1071-3581",

publisher = "Springer New York",

number = "5",

}

TY - JOUR

T1 - Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic

T2 - An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America

AU - Skali, Hicham

AU - Murthy, Venkatesh L.

AU - Paez, Diana

AU - Choi, Elisa M.

AU - Keng, Felix Y.J.

AU - Iain, McGhie G.A.

AU - Al-Mallah, Mouaz

AU - Campisi, Roxana

AU - Bateman, Timothy M.

AU - Carrio, Ignasi

AU - Beanlands, Rob

AU - Calnon, Dennis A.

AU - Dilsizian, Vasken

AU - Dondi, Maurizio

AU - Gimelli, Alessia

AU - Pagnanelli, Robert

AU - Polk, Donna M.

AU - Soman, Prem

AU - Einstein, Andrew J.

AU - Dorbala, Sharmila

AU - Thompson, Randall C.

N1 - Funding Information: Dr. Bateman: Activities related to the present article: No relevant relationships. Activities not related to the present article: Research Grants: Bracco, GE Healthcare, Jubilant DraxImage. Consultant: AIM, AstraZeneca, Curium, GEHC. Royalties: SPECT and PET software products. Ownership interest: CVIT. Dr. Beanlands: Activities related to the present article: No relevant relationships. Activities not related to the present article: Grants/Honoraria from Jubilant DraxImage, LMI, GE Healthcare. Dr. Dorbala: Activities related to the present article: No relevant relationships. Activities not related to the present article: Grants and Honoraria from Pfizer and GE Healthcare. Institution has grants/grants pending from National Institutes of Health and International Atomic Energy Agency. Dr. Einstein: Activities related to the present article: No relevant relationships. Activities not related to the present article: Consultant for GE Healthcare and W. L. Gore and Associates; institution has grants/grants pending from National Institutes of Health, International Atomic Energy Agency, Canon Medical Systems, Roche Medical Systems, and W. L. Gore and Associates; received travel/accommodations/meeting expenses unrelated to activities listed from HeartFlow. Dr. Murthy: Activities related to the present article: No relevant relationships. Activities not related to the present article: Owns stock in General Electric and Cardinal Health and stock options in Ionetix. He has served as a paid advisor to Ionetix and Covidien. He has received research grants from Siemens and non-financial research support from INVIA Medical Imaging Solutions. He has received payment on behalf of Jubilant Draximage for expert witness testimony. Dr. Soman: Activities related to the present article: No relevant relationships. Activities not related to the present article: Serves on the advisory board of Alnylam Pharmaceuticals and is the principal investigator of a grant from Astellas Pharmaceuticals to the University of Pittsburgh. The remaining authors have no relevant relationships. Funding Information: Dr. Bateman: Activities related to the present article: No relevant relationships. Activities not related to the present article: Research Grants: Bracco, GE Healthcare, Jubilant DraxImage. Consultant: AIM, AstraZeneca, Curium, GEHC. Royalties: SPECT and PET software products. Ownership interest: CVIT. Dr. Beanlands: Activities related to the present article: No relevant relationships. Activities not related to the present article: Grants/Honoraria from Jubilant DraxImage, LMI, GE Healthcare. Dr. Dorbala: Activities related to the present article: No relevant relationships. Activities not related to the present article: Grants and Honoraria from Pfizer and GE Healthcare. Institution has grants/grants pending from National Institutes of Health and International Atomic Energy Agency. Dr. Einstein: Activities related to the present article: No relevant relationships. Activities not related to the present article: Consultant for GE Healthcare and W. L. Gore and Associates; institution has grants/grants pending from National Institutes of Health, International Atomic Energy Agency, Canon Medical Systems, Roche Medical Systems, and W. L. Gore and Associates; received travel/accommodations/meeting expenses unrelated to activities listed from HeartFlow. Dr. Murthy: Activities related to the present article: No relevant relationships. Activities not related to the present article: Owns stock in General Electric and Cardinal Health and stock options in Ionetix. He has served as a paid advisor to Ionetix and Covidien. He has received research grants from Siemens and non-financial research support from INVIA Medical Imaging Solutions. He has received payment on behalf of Jubilant Draximage for expert witness testimony. Dr. Soman: Activities related to the present article: No relevant relationships. Activities not related to the present article: Serves on the advisory board of Alnylam Pharmaceuticals and is the principal investigator of a grant from Astellas Pharmaceuticals to the University of Pittsburgh. The remaining authors have no relevant relationships.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85086875183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086875183&partnerID=8YFLogxK

U2 - 10.1007/s12350-020-02203-3

DO - 10.1007/s12350-020-02203-3

M3 - Article

C2 - 32710257

AN - SCOPUS:85086875183

SN - 1071-3581

VL - 27

SP - 1855

EP - 1862

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

IS - 5

ER -

Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI: Endorsed by the Infectious Diseases Society of America

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this